Search
View Show Page
JACC Specialty Journals
JACC: Advances - Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
Feb 28, 2024
3:00
Save
Follow
Share
Science
Episode Description
Commentary by Dr. Candice Silversides
Listen On
How to rate & review on Apple Podcasts
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows